Rapid acceleration of diagnostics (radx) program tech

Ended Purchase Order Awarded Last action

Contract number
75N92021P00054
Awardee
Awarding agency
Obligated
$250,000

Award facts

Contract value 100% obligated
$250,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Chicago, IL 60654, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · Rapid acceleration of diagnostics (radx) program tech edited by learj_NIH on 11/30/2021 12:06:52 $0
Original award $250,000

About this award

The Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute awarded a $250,000 firm fixed price purchase order to Arete Biosciences, LLC of Chicago, Illinois. The contract is to support the Rapid Acceleration of Diagnostics (RADX) Program Technology effort through January 18, 2022. No major subcontractors or set aside designations were indicated. The award provides funding for Arete Biosciences to likely deliver diagnostic technologies or services to the NIH's RADX Program, which aims to speed innovation in the development and commercialization of COVID-19 testing technologies.

Quick answers

Who was awarded contract 75N92021P00054?

75N92021P00054 was awarded to Arete Biosciences, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on January 19, 2021.

How much is contract 75N92021P00054 worth?

The government has obligated $250,000 on 75N92021P00054.

Was contract 75N92021P00054 competed?

The extent of competition for 75N92021P00054 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award